Effect of clomiphene citrate on hormonal profile in male hemodialysis and kidney transplant patients.
The aim of this study was to evaluate the role of clomiphene citrate (CC) therapy in the hypothalamus-pituitary-gonadal axis of male uremic subjects. Thirty-four patients on hemodialysis (HD) and 8 successful kidney transplant subjects (RT) were evaluated. Nine healthy males were used as controls (C). At baseline, zinc, testosterone (TEST), prolactin (PRL), FSH, LH and estradiol plasma concentrations were measured. All subjects were treated with CC (100 mg/day) for a week. The aforementioned parameters were determined again on the seventh day of CC therapy, and 3 days after drug withdrawal. Following CC, there was a rise in FSH, LH and TEST levels in all subjects (p < 0.05); it is interesting to stress that TEST became normal in HD. In addition, we observed a decrease of PRL after CC only in HD patients (p < 0.01). In summary, CC was able to partially correct most of the hormonal disturbances of the gonadal axis in uremic patients.
Martin-Malo
A
A
Department of Nephrology, Hospital Universitario Reina Sofia, Cordoba, Spain.
Benito
P
P
Castillo
D
D
Espinosa
M
M
Burdiel
L G
LG
Perez
R
R
Aljama
P
P
D000328:Adult; D002996:Clomiphene / Q000627:therapeutic use*; D004958:Estradiol / Q000097:blood; D005640:Follicle Stimulating Hormone / Q000097:blood; D006728:Hormones / Q000097:blood*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D016030:Kidney Transplantation / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood; D006435:Renal Dialysis; D013737:Testis / Q000187:drug effects; D013739:Testosterone / Q000097:blood; D014511:Uremia / Q000097:blood / Q000188:drug therapy / Q000628:therapy; D015032:Zinc / Q000097:blood
D006728:Hormones; D002996:Clomiphene; D013739:Testosterone; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D015032:Zinc